Longhorn Vaccines and Diagnostics to Present Late-Breaking Poster at ESCMID 2025 on LHNVD-303 to Treat and Prevent Antimicrobial Resistance

Written By Van Agens
Van Agens
Next

Longhorn Vaccines and Diagnostics Partners with Promega to Combine Complementary Offerings for Enhanced Sample Collection, Transport and Analysis